Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating peripheral stem cell transplantation with combination chemotherapy and monoclonal antibody therapy for lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Lymphoma | Phase 2 | Status: COMPLETED